Company Filing History:
Years Active: 2018-2021
Title: The Innovative Contributions of Ben Draper
Introduction
Ben Draper is a notable inventor based in London, GB. He has made significant contributions to the field of biomedical engineering, particularly in the development of chimeric antigen receptors and variants of proliferation-inducing ligands. With a total of 4 patents to his name, Draper continues to push the boundaries of innovation in medical treatments.
Latest Patents
Draper's latest patents include groundbreaking inventions that have the potential to transform the treatment of plasma-cell mediated diseases. One of his key inventions is a chimeric antigen receptor (CAR) that comprises a B cell maturation antigen (BCMA)-binding domain, a spacer domain, a transmembrane domain, and an intracellular T cell signaling domain. This invention is particularly relevant for the treatment of multiple myeloma. Another significant patent is for variants of the proliferation-inducing ligand (APRIL), which exhibit a higher binding affinity to BCMA than the wild-type APRIL. These variants also demonstrate altered binding kinetics and a higher BCMA:TACI binding ratio, showcasing Draper's innovative approach to enhancing therapeutic efficacy.
Career Highlights
Throughout his career, Ben Draper has worked with prominent companies in the biotechnology sector. He has been associated with UCL Business Plc and Autolus Limited, where he has contributed to various research and development projects. His work has been instrumental in advancing the understanding and treatment of complex diseases.
Collaborations
Draper has collaborated with esteemed colleagues in the field, including Martin Pulé and Kwee L Yong. These collaborations have fostered a rich exchange of ideas and have led to significant advancements in their respective areas of expertise.
Conclusion
Ben Draper is a distinguished inventor whose work in the field of biomedical engineering has the potential to make a lasting impact on medical treatments. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.